$12.5 million study aims to improve postpartum blood pressure management

Researchers at the Perelman School of Medicine at the University of Pennsylvania are launching a $12.5 million study to improve postpartum blood pressure management and long-term cardiovascular health for patients with hypertensive disorders during pregnancy.

Pharmala Biotech: CEO Letter To Shareholders | Psychedelic Invest

Over the past 48 hours, a large number of shareholders have reached out to me for my thoughts on the recent FDA Advisory Committee Meeting

June 7, 2024

Kodiak ‘reboots’ Eylea competitor after positive data in diabetic vision loss trial

Despite two failed late-stage trials, Palo Alto-based biotech Kodiak Sciences said it’s going to restart development of its potential Eylea rival after it met all

November 7, 2023

Hematocrit Stabilized in Polycythemia Vera Treated With Novel Hepcidin Mimetic

SAN DIEGO — A novel therapy for polycythemia vera (PCV) maintained stable hematocrit levels for as long as 2.5 years and significantly reduced use of

December 16, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.